Abstract: An adjustable support for an electronic device including a platform configured to support the electronic device, a post extending between a first end and a second end, a linkage assembly movably supporting the platform on the post, where the linkage assembly is slidably coupled to the post to adjust a height of the platform, and where the linkage assembly includes a plurality of movable linkages configured to adjust a tilt of the platform to a plurality of different tilt angles.

Abstract: An adjustable support for an electronic device including a platform configured to support the electronic device, a post extending between a first end and a second end, a linkage assembly movably supporting the platform on the post, where the linkage assembly is slidably coupled to the post to adjust a height of the platform, and where the linkage assembly includes a plurality of movable linkages configured to adjust a tilt of the platform to a plurality of different tilt angles.

Abstract: A method of obtaining a clinical assessment of a user of a user device may include obtaining, by the user device and from a hand-held diagnostic device configured to communicate with the user device, first diagnostic information of the user obtained by one or more sensors of the hand-held diagnostic device; obtaining, by the user device, second diagnostic information based on a user input of the second diagnostic information via the user device; obtaining, by the user device and using an artificial intelligence (AI) model, the clinical assessment based on the first diagnostic information and the second diagnostic information; and displaying, by the user device, the clinical assessment to permit the user to visualize the clinical assessment.

Abstract: A method of obtaining a clinical assessment of a user of a user device may include obtaining, by the user device and from a hand-held diagnostic device configured to communicate with the user device, first diagnostic information of the user obtained by one or more sensors of the hand-held diagnostic device; obtaining, by the user device, second diagnostic information based on a user input of the second diagnostic information via the user device; obtaining, by the user device and using an artificial intelligence (AI) model, the clinical assessment based on the first diagnostic information and the second diagnostic information; and displaying, by the user device, the clinical assessment to permit the user to visualize the clinical assessment.

Abstract: An adjustable support for an electronic device including a platform configured to support the electronic device, a post extending between a first end and a second end, a linkage assembly movably supporting the platform on the post, where the linkage assembly is slidably coupled to the post to adjust a height of the platform, and where the linkage assembly includes a plurality of movable linkages configured to adjust a tilt of the platform to a plurality of different tilt angles.

Abstract: A method of obtaining a clinical assessment of a user of a user device may include obtaining, by the user device and from a hand-held diagnostic device configured to communicate with the user device, first diagnostic information of the user obtained by one or more sensors of the hand-held diagnostic device; obtaining, by the user device, second diagnostic information based on a user input of the second diagnostic information via the user device; obtaining, by the user device and using an artificial intelligence (AI) model, the clinical assessment based on the first diagnostic information and the second diagnostic information; and displaying, by the user device, the clinical assessment to permit the user to visualize the clinical assessment.

Abstract: Provided are knottin-drug conjugates. The conjugates include a knottin peptide that includes an engineered loop that binds to a target on a cancer cell surface, and a drug (e.g., a nucleoside drug) conjugated to the knottin peptide through a linker. Also provided are pharmaceutical compositions and kits that include the knottin-drug conjugates, as well as methods of using the knottin-drug conjugates, e.g., for therapeutic purposes.

Abstract: Provided are knottin-drug conjugates. The conjugates include a knottin peptide that includes an engineered loop that binds to a target on a cancer cell surface, and a drug (e.g., a nucleoside drug) conjugated to the knottin peptide through a linker. Also provided are pharmaceutical compositions and kits that include the knottin-drug conjugates, as well as methods of using the knottin-drug conjugates, e.g., for therapeutic purposes.

Abstract: Provided are knottin-drug conjugates. The conjugates include a knottin peptide that includes an engineered loop that binds to a target on a cancer cell surface, and a drug (e.g., a nucleoside drug) conjugated to the knottin peptide through a linker. Also provided are pharmaceutical compositions and kits that include the knottin-drug conjugates, as well as methods of using the knottin-drug conjugates, e.g., for therapeutic purposes.

Abstract: A refrigerant that is azeotropic or near-azeotropic comprises a binary blend of R744 and R41. In one embodiment the binary blend has a molar composition of 20 to 60 percent R744, the remainder being R41.

Abstract: A refrigerant that is azeotropic or near-azeotropic comprises a binary blend of R744 and R41. In one embodiment the binary blend has a molar composition of 20 to 60 percent R744, the remainder being R41.

Abstract: A refrigerant that is azeotropic or near-azeotropic comprises a binary blend of R744 and R41. In one embodiment the binary blend has a molar composition of 20 to 60 percent R744, the remainder being R41.

Abstract: This invention relates to a refrigerant that is azeotropic or near-azeotropic and comprises a binary blend of R1270 and R161, R170 and R717, or R744 and R41. In a first embodiment, the binary blend has a molar composition of 50 to 80 percent R1270, the remainder being R161. In a second embodiment, the binary blend has a molar composition of 30 to 60 percent R717, the remainder being R170. In a third embodiment the binary blend has a molar composition of 20 to 60 percent R744, the remainder being R161.

Abstract: This invention relates to a refrigerant that is azeotropic or near-azeotropic and comprises a binary blend of R1270 and R161, R170 and R717, or R744 and R41. In a first embodiment, the binary blend has a molar composition of 50 to 80 percent R1270, the remainder being R161. In a second embodiment, the binary blend has a molar composition of 30 to 60 percent R717, the remainder being R170. In a third embodiment the binary blend has a molar composition of 20 to 60 percent R744, the remainder being R161.

Abstract: Various embodiments of a plastic blister system are shown and described. The blister system is comprised of a blister to which a lid or backing of the same material may be tightly fitted and sealed by virtue of one or more cooperating "steps" near the outer perimeters of the blister and or lid, and by virtue of the outer perimeters of the blister and lid being continuously sealed to the cardboard or other planar sheet of backing. When the blister pack is thus sealed and attached to the cardboard, any odors or vapors which may possibly emit from the product, which is encased within the sealed blister, are also totally sealed in and cannot escape. Also, the sealed blister prevents outside moisture and gasses from contacting the product until the blister is opened.